Structure of Prostaglandin D2
CAS No.: 41598-07-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Prostaglandin D2 is the major eicosanoid product of mast cells and is released in large quantities during allergic and asthmatic anaphylaxis.
Synonyms: PGD2
4.5
*For Research Use Only !
Change View
| Size | Price | VIP Price |
DE Stock US Stock |
Asia Stock Global Stock |
In Stock |
| {[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.p_spot_brand_remark ]} 1-2 weeks {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock Inquiry - | Login - + |
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ item.p_spot_brand_remark ]}
1-2weeks
Inquiry
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
Asia Stock: Ship in 3-5 business days
EU Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
| CAS No. : | 41598-07-6 |
| Formula : | C20H32O5 |
| M.W : | 352.47 |
| SMILES Code : | O=C(O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)C(C[C@@H]1O)=O |
| Synonyms : |
PGD2
|
| MDL No. : | MFCD00077857 |
| GHS Pictogram: |
|
| Signal Word: | Danger |
| Hazard Statements: | H302-H360 |
| Precautionary Statements: | P201-P202-P264-P5172-P270-P280-P301+P312+P330-P308+P313-P405-P501 |
Clinical Trial:
| NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
| NCT02237365 | Tuberculous Meningitis | Phase 2 | Completed | - | Vietnam ... More >> Hospital for Tropical Diseases Ho Chi Minh City, Vietnam Less << |
| NCT02752048 | Duchenne Muscular Dystrophy | Phase 2 | Completed | - | Japan ... More >> Nagoya City University Hospital Aichi, Japan, 467-8601 National Hospital Organization Nagara Medical Center Gifu, Japan, 502-8558 Kobe University Hospital Hyogo, Japan, 650-0017 National Hospital Organization Utano Hospital Kyoto, Japan, 616-8255 Shinshu University Hospital Nagano, Japan, 390-8621 National Hospital Organization Niigata National Hospital Niigata, Japan, 945-8585 National Hospital Organization Toneyama National Hospital Osaka, Japan, 560-8552 National Hospital Organization Higashisaitama Hospital Saitama, Japan, 349-0196 Tokyo Women's Medical University Hospital Tokyo, Japan, 162-8666 National Center of Neurology and Psychiatry Tokyo, Japan, 187-8551 Tottori University Hospital Tottori, Japan, 683-8504 Less << |
| NCT02064738 | ASA Triad Ast... More >>hma, Nasal Polyps, And Aspirin Intolerance Less << | Not Applicable | Unknown | - | United States, Massachusetts ... More >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Tanya M Laidlaw, MD 617-525-1034 tlaidlaw@partners.org Principal Investigator: Tanya M Laidlaw, MD Sub-Investigator: Katherine N Cahill, MD Sub-Investigator: Paige Wickner, MD Sub-Investigator: Juan Carlos Cardet, MD Less << |
| NCT01002690 | Asthma | Not Applicable | Completed | - | Sweden ... More >> Karolinska University Hospital Stockholm, Sweden, SE-141 86 Less << |
| NCT02052908 | Lynch Syndrome | Phase 1 | Active, not recruiting | - | United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Less << |
| NCT03595488 | Aspirin-exacerbated Respirator... More >>y Disease Less << | Phase 2 | Recruiting | August 2020 | United States, New York ... More >> Rochester Regional Health - Allergy/Immunology Recruiting Rochester, New York, United States, 14607 Contact: S Shahzad Mustafa, MD 585-922-8350 Less << |
| NCT03306589 | Arthritis, Rheumatoid | Phase 1 | Completed | - | United Kingdom ... More >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG Less << |
| NCT00784732 | Seasonal Allergic Rhinitis | Phase 2 | Completed | - | Canada ... More >> Novartis Investigator Site Toronto, Canada Less << |
| NCT01173770 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> Simbec Merthyr Tydfil, United Kingdom, CF48 4DR Less << |
| NCT02090374 | Allergic Rhinitis ... More >> Asthma Latent Tuberculosis Less << | Not Applicable | Completed | - | United Kingdom ... More >> Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's Hospital Paddington, London, United Kingdom, W2 1NY Less << |
| NCT01618929 | Bronchial Asthma ... More >> Food Allergy Children Less << | Phase 4 | Completed | - | Turkey ... More >> Cansin Sackesen Ankara, Turkey, 06100 Less << |
| NCT01281111 | Healthy | Phase 1 | Completed | - | United States, Minnesota ... More >> Research Site St. Paul, Minnesota, United States, 55114 Less << |
| NCT02660489 | Asthma Rhinov... More >>irus Picornaviridae Infections Common Cold Less << | Phase 2 | Unknown | February 2018 | United Kingdom ... More >> St Mary's Hospital Recruiting London, Greater London, United Kingdom, W2 1PG Contact: Hugo Farne, BMBCh MA 07590 250487 asthma.trial@imperial.ac.uk Contact: Maria-Belén Trujillo-Torralbo, BSc 07590 250487 asthma.trial@imperial.ac.uk Less << |
| NCT03406325 | - | Recruiting | June 2019 | Hong Kong ... More >> Hong Kong Sanatorium & Hospital Recruiting Hong Kong, Hong Kong Less << | |
| NCT01545726 | Asthma | Phase 2 | Completed | - | United Kingdom ... More >> Novartis Investigative Site Leicester, United Kingdom, LE3 9QP Less << |
| NCT01097694 | Asthma | Phase 2 | Completed | - | United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Massachusetts Brigham and Womens Hospital Boston, Massachusetts, United States, 02115 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Columbia University New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Temple University Philadelphia, Pennsylvania, United States, 19140 United States, Wisconsin University of Wisconsin Madison, Wisconsin, United States, 53792 Less << |
| NCT02412605 | - | Unknown | - | Egypt ... More >> Dar AlTeb subfertility centre Recruiting Giza, Egypt Contact: AbdelGany MA Hassan, MRCOG, MD 00217801604 abdelgany2@gmail.com Sub-Investigator: Ahmed MA AwadAllah, MD Principal Investigator: AbdelGany MA Hassan, MRCOG, MD Sub-Investigator: Mohamed MM Kotb, MD Less << | |
| NCT01605487 | Cold Contact Urticaria | Phase 2 | Completed | - | Germany ... More >> Department of Dermatology and Allergy Charité - Universitätsmedizin Berlin, Charitéplatz 1, Germany, 10117 Berlin Less << |
| NCT03524053 | Exercise Induced Asthma | Not Applicable | Not yet recruiting | March 2020 | United Kingdom ... More >> Brunel University London Not yet recruiting Uxbridge, Middlesex, United Kingdom, UB8 3PH Contact: Hannah Marshall, MSc +447584168742 hannah.marshall@brunel.ac.uk Contact: Pascale Kippelen, PhD 01895267649 pascale.kippelen@brunel.ac.uk Less << |
| NCT01942291 | Hypoalphalipoproteinemia | Phase 4 | Completed | - | Brazil ... More >> University of Campinas Campinas, SP, Brazil, 13083-887 Less << |
| NCT03365648 | Allergic Rhinoconjunctivitis | Not Applicable | Completed | - | Italy ... More >> Fondazione IRCCS Policlinico San Matteo Pavia, (pv), Italy, 27100 Ospedale regionale San Salvatore - ASL 1 Avezzano Sulmona L'Aquila L'Aquila, AQ, Italy, 67100 A.O.U. Consorziale "Policlinico Giovanni XXIII" Bari, BA, Italy, 70126 A.O.U. Consorziale "Policlinico-Giovanni XXIII" Bari, BA, Italy, 70126 A.O.U. Policlinico Vittorio Emanuele Catania, CT, Italy, 95123 Istituto Giannina Gaslini Genova, GE, Italy, 16132 P.O. San Giovanni di Dio - ASP di Crotone Crotone, KR, Italy, 88900 A.O.U. Policlinico "G. Martino" Messina, ME, Italy, 98124 P.O. G. Salvini di Garbagnate Milanese - ASST Rhodense Garbagnate Milanese, MI, Italy, 20042 Ospedale Civile di Legnano - ASST Ovest Milanese Legnano, MI, Italy, 20162 Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, MI, Italy, 20122 Ospedale San Carlo Borromeo - ASST Azienda Socio Sanitaria Territoriale Santi Paolo E Carlo Milano, MI, Italy, 20157 Ospedale Città di Sesto San Giovanni - ASST Nord Milano Sesto San Giovanni, MI, Italy, 20099 Ospedale di Polistena "Santa Maria degli Ungheresi" - ASP di Reggio Calabria Polistena, RC, Italy, 89024 A.O.U. Policlinico Umberto I Roma, RM, Italy, 00161 P.O. di Busto Arsizio - ASST Valle Olona Busto Arsizio, VA, Italy, 21051 Az. Osp. Univ. dell'Università degli Studi della Campania "Luigi Vanvitelli" Napoli, Italy, 80138 Less << |
| NCT03441438 | Aspirin-Sensitive Asthma With ... More >>Nasal Polyps Samter's Syndrome Less << | Not Applicable | Recruiting | September 1, 2018 | United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: BJ Ferrebee-Ghamandi, MHA 434-243-1558 Bjf8j@hscmail.mcc.virginia.edu Less << |
| NCT00399633 | Healthy Migra... More >>ine Less << | Not Applicable | Completed | - | Denmark ... More >> Danish Headache Center Glostrup, Copenhagen, Copenhagen, Denmark, 2600 Less << |
| NCT00426179 | Seasonal Allergic Rhinitis | Phase 1 Phase 2 | Completed | - | United Kingdom ... More >> Novartis Investigative site Horsham, United Kingdom Less << |
| NCT02031679 | Chronic Idiopathic Urticaria | Phase 2 | Completed | - | United States, Maryland ... More >> Johns Hopkins Asthma and Allergy Center Baltimore, Maryland, United States, 21224-6821 Less << |
| NCT03662269 | Refractory Chronic Cough | Phase 3 | Recruiting | December 30, 2020 | China, Guangdong ... More >> The First Affiliated Hospital Of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 520120 Contact: Kefang Lai, PHD 83062893 ext 020 klai@163.com Principal Investigator: Kefang Lai, PHD Less << |
| NCT02031679 | - | Completed | - | - | |
| NCT01097694 | - | Completed | - | - | |
| NCT01275300 | Healthy Volunteer | Phase 4 | Completed | - | United States, Pennsylvania ... More >> University of Pennsylvania Hospital Phila., Pennsylvania, United States, 19104 Less << |
| NCT01179282 | ALLERGIC RHINITIS | Not Applicable | Completed | - | United States, Florida ... More >> Usf Asthma Allergy and Immunology Cru Tampa, Florida, United States, 33613 Less << |
| NCT03369704 | Seasonal Allergic Rhinitis | Phase 3 | Completed | - | Japan ... More >> Novartis Investigative Site Chiba-city, Chiba, Japan, 262-0015 Novartis Investigative Site Ichikawa-city, Chiba, Japan, 272-0143 Novartis Investigative Site Kashiwa-city, Chiba, Japan, 2270082 Novartis Investigative Site Matsudo-city, Chiba, Japan, 270-0034 Novartis Investigative Site Matsudo-city, Chiba, Japan, 2710077 Novartis Investigative Site Urayasu city, Chiba, Japan, 279-0012 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 212-0027 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 216 0006 Novartis Investigative Site Kawasaki-city, Kanagawa, Japan, 216-0002 Novartis Investigative Site Yokohama-city, Kanagawa, Japan Novartis Investigative Site Koshigaya-city, Saitama, Japan, 343-0031 Novartis Investigative Site Arakawa-ku, Tokyo, Japan, 116 0011 Novartis Investigative Site Chiyoda-ku, Tokyo, Japan, 101-0063 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 103-0027 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 132-0014 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 125-0061 Novartis Investigative Site Nakano-ku, Tokyo, Japan, 164-0012 Novartis Investigative Site Setagaya-ku, Tokyo, Japan, 158-0097 Novartis Investigative Site Shinjuku ku, Tokyo, Japan, 160-0008 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan, 160-0017 Novartis Investigative Site Shinjuku-ku, Tokyo, Japan Novartis Investigative Site Toshima-Ku, Tokyo, Japan, 170-0005 Less << |
| NCT03665701 | Atopic Asthma | Not Applicable | Enrolling by invitation | December 31, 2018 | Germany ... More >> Fraunhofer ITEM im CRC Hannover, Niedersachsen, Germany, 30625 Less << |
| NCT01001260 | - | Terminated(Unable to find subj... More >>ects that met inclusion/exclusion criteria.) Less << | - | - | |
| NCT01052311 | Coronary Artery Disease ... More >> Dyslipidemia Less << | Phase 4 | Terminated(The sponsor decided... More >> to withdraw study drug from market) Less << | - | Israel ... More >> Leviev Heart Center, Sheba Medical Center Tel Hashomer, Israel, 52621 Less << |
| NCT00930839 | - | Completed | - | United States, Virginia ... More >> Eastern Virgnia Medical School, Strelitz Diabetes Center Norfolk, Virginia, United States, 23510f Less << |
Tags: Prostaglandin D2 | PGD2 | Endogenous Metabolite | Prostaglandin Receptor | Others | Structure | Steroids | GPCR/G Protein | Biological Buffers | Fluorescence Labeling Reagents | Fluorescent Dyes | Small Molecule Positive Drugs | Other Inhibitors/Agonists | 41598-07-6
Precautionary Statements-General | |
| Code | Phrase |
| P101 | If medical advice is needed,have product container or label at hand. |
| P102 | Keep out of reach of children. |
| P103 | Read label before use |
Prevention | |
| Code | Phrase |
| P201 | Obtain special instructions before use. |
| P202 | Do not handle until all safety precautions have been read and understood. |
| P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
| P211 | Do not spray on an open flame or other ignition source. |
| P220 | Keep/Store away from clothing/combustible materials. |
| P221 | Take any precaution to avoid mixing with combustibles |
| P222 | Do not allow contact with air. |
| P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
| P230 | Keep wetted |
| P231 | Handle under inert gas. |
| P232 | Protect from moisture. |
| P233 | Keep container tightly closed. |
| P234 | Keep only in original container. |
| P235 | Keep cool |
| P240 | Ground/bond container and receiving equipment. |
| P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
| P242 | Use only non-sparking tools. |
| P243 | Take precautionary measures against static discharge. |
| P244 | Keep reduction valves free from grease and oil. |
| P250 | Do not subject to grinding/shock/friction. |
| P251 | Pressurized container: Do not pierce or burn, even after use. |
| P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
| P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
| P262 | Do not get in eyes, on skin, or on clothing. |
| P263 | Avoid contact during pregnancy/while nursing. |
| P264 | Wash hands thoroughly after handling. |
| P265 | Wash skin thouroughly after handling. |
| P270 | Do not eat, drink or smoke when using this product. |
| P271 | Use only outdoors or in a well-ventilated area. |
| P272 | Contaminated work clothing should not be allowed out of the workplace. |
| P273 | Avoid release to the environment. |
| P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
| P281 | Use personal protective equipment as required. |
| P282 | Wear cold insulating gloves/face shield/eye protection. |
| P283 | Wear fire/flame resistant/retardant clothing. |
| P284 | Wear respiratory protection. |
| P285 | In case of inadequate ventilation wear respiratory protection. |
| P231 + P232 | Handle under inert gas. Protect from moisture. |
| P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
| Code | Phrase |
| P301 | IF SWALLOWED: |
| P304 | IF INHALED: |
| P305 | IF IN EYES: |
| P306 | IF ON CLOTHING: |
| P307 | IF exposed: |
| P308 | IF exposed or concerned: |
| P309 | IF exposed or if you feel unwell: |
| P310 | Immediately call a POISON CENTER or doctor/physician. |
| P311 | Call a POISON CENTER or doctor/physician. |
| P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
| P313 | Get medical advice/attention. |
| P314 | Get medical advice/attention if you feel unwell. |
| P315 | Get immediate medical advice/attention. |
| P320 | |
| P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
| P321 | |
| P322 | |
| P330 | Rinse mouth. |
| P331 | Do NOT induce vomiting. |
| P332 | IF SKIN irritation occurs: |
| P333 | If skin irritation or rash occurs: |
| P334 | Immerse in cool water/wrap n wet bandages. |
| P335 | Brush off loose particles from skin. |
| P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
| P337 | If eye irritation persists: |
| P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
| P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P342 | If experiencing respiratory symptoms: |
| P350 | Gently wash with plenty of soap and water. |
| P351 | Rinse cautiously with water for several minutes. |
| P352 | Wash with plenty of soap and water. |
| P353 | Rinse skin with water/shower. |
| P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
| P361 | Remove/Take off immediately all contaminated clothing. |
| P362 | Take off contaminated clothing and wash before reuse. |
| P363 | Wash contaminated clothing before reuse. |
| P370 | In case of fire: |
| P371 | In case of major fire and large quantities: |
| P372 | Explosion risk in case of fire. |
| P373 | DO NOT fight fire when fire reaches explosives. |
| P374 | Fight fire with normal precautions from a reasonable distance. |
| P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
| P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
| P378 | |
| P380 | Evacuate area. |
| P381 | Eliminate all ignition sources if safe to do so. |
| P390 | Absorb spillage to prevent material damage. |
| P391 | Collect spillage. Hazardous to the aquatic environment |
| P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
| P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
| P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
| P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
| P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
| P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
| P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
| P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
| P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
| P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
| P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
| P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
| P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
| P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
| P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
| P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
| P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
| P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
| P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
| P370 + P376 | In case of fire: Stop leak if safe to Do so. |
| P370 + P378 | In case of fire: |
| P370 + P380 | In case of fire: Evacuate area. |
| P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
| P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
| Code | Phrase |
| P401 | |
| P402 | Store in a dry place. |
| P403 | Store in a well-ventilated place. |
| P404 | Store in a closed container. |
| P405 | Store locked up. |
| P406 | Store in corrosive resistant/ container with a resistant inner liner. |
| P407 | Maintain air gap between stacks/pallets. |
| P410 | Protect from sunlight. |
| P411 | |
| P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
| P413 | |
| P420 | Store away from other materials. |
| P422 | |
| P402 + P404 | Store in a dry place. Store in a closed container. |
| P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
| P403 + P235 | Store in a well-ventilated place. Keep cool. |
| P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
| P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
| P411 + P235 | Keep cool. |
Disposal | |
| Code | Phrase |
| P501 | Dispose of contents/container to ... |
| P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
| Code | Phrase |
| H200 | Unstable explosive |
| H201 | Explosive; mass explosion hazard |
| H202 | Explosive; severe projection hazard |
| H203 | Explosive; fire, blast or projection hazard |
| H204 | Fire or projection hazard |
| H205 | May mass explode in fire |
| H220 | Extremely flammable gas |
| H221 | Flammable gas |
| H222 | Extremely flammable aerosol |
| H223 | Flammable aerosol |
| H224 | Extremely flammable liquid and vapour |
| H225 | Highly flammable liquid and vapour |
| H226 | Flammable liquid and vapour |
| H227 | Combustible liquid |
| H228 | Flammable solid |
| H229 | Pressurized container: may burst if heated |
| H230 | May react explosively even in the absence of air |
| H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
| H240 | Heating may cause an explosion |
| H241 | Heating may cause a fire or explosion |
| H242 | Heating may cause a fire |
| H250 | Catches fire spontaneously if exposed to air |
| H251 | Self-heating; may catch fire |
| H252 | Self-heating in large quantities; may catch fire |
| H260 | In contact with water releases flammable gases which may ignite spontaneously |
| H261 | In contact with water releases flammable gas |
| H270 | May cause or intensify fire; oxidizer |
| H271 | May cause fire or explosion; strong oxidizer |
| H272 | May intensify fire; oxidizer |
| H280 | Contains gas under pressure; may explode if heated |
| H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
| H290 | May be corrosive to metals |
Health hazards | |
| Code | Phrase |
| H300 | Fatal if swallowed |
| H301 | Toxic if swallowed |
| H302 | Harmful if swallowed |
| H303 | May be harmful if swallowed |
| H304 | May be fatal if swallowed and enters airways |
| H305 | May be harmful if swallowed and enters airways |
| H310 | Fatal in contact with skin |
| H311 | Toxic in contact with skin |
| H312 | Harmful in contact with skin |
| H313 | May be harmful in contact with skin |
| H314 | Causes severe skin burns and eye damage |
| H315 | Causes skin irritation |
| H316 | Causes mild skin irritation |
| H317 | May cause an allergic skin reaction |
| H318 | Causes serious eye damage |
| H319 | Causes serious eye irritation |
| H320 | Causes eye irritation |
| H330 | Fatal if inhaled |
| H331 | Toxic if inhaled |
| H332 | Harmful if inhaled |
| H333 | May be harmful if inhaled |
| H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
| H335 | May cause respiratory irritation |
| H336 | May cause drowsiness or dizziness |
| H340 | May cause genetic defects |
| H341 | Suspected of causing genetic defects |
| H350 | May cause cancer |
| H351 | Suspected of causing cancer |
| H360 | May damage fertility or the unborn child |
| H361 | Suspected of damaging fertility or the unborn child |
| H361d | Suspected of damaging the unborn child |
| H362 | May cause harm to breast-fed children |
| H370 | Causes damage to organs |
| H371 | May cause damage to organs |
| H372 | Causes damage to organs through prolonged or repeated exposure |
| H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
| Code | Phrase |
| H400 | Very toxic to aquatic life |
| H401 | Toxic to aquatic life |
| H402 | Harmful to aquatic life |
| H410 | Very toxic to aquatic life with long-lasting effects |
| H411 | Toxic to aquatic life with long-lasting effects |
| H412 | Harmful to aquatic life with long-lasting effects |
| H413 | May cause long-lasting harmful effects to aquatic life |
| H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL


